Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 53,442 | 55,199 | 52,790 | 45,539 | 44,034 |
| Accounts receivable | 6,534 | -18,059 | -12,629 | -19,585 | -56,238 |
| Other Working Capital | -9,588 | -62,989 | -14,323 | -152,738 | -232,077 |
| Other Operating Activity | 235,895 | 263,285 | 256,727 | 255,420 | 288,943 |
| Operating Cash Flow | $286,283 | $237,436 | $282,565 | $128,636 | $44,662 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30,035 | -34,449 | -28,817 | -27,350 | -29,056 |
| Net Acquisitions | -103,183 | -1,524 | 0 | -992,125 | -19,100 |
| Purchase Of Investment | -5,181 | -2,500 | -12,597 | -9,799 | -7,333 |
| Sale Of Investment | 250 | -3,765 | 15,717 | N/A | N/A |
| Purchase Sale Intangibles | -10,831 | -4,285 | -2,407 | -4,319 | -3,317 |
| Other Investing Activity | 0 | 0 | 0 | 7,181 | 0 |
| Investing Cash Flow | $-148,980 | $-46,523 | $-28,104 | $-1,026,412 | $-58,806 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 105,000 | 0 | 0 | 1,020,000 | 50,000 |
| Debt Repayment | -185,000 | -145,000 | -215,000 | -15,000 | -30,000 |
| Common Stock Issued | 983 | 23,493 | 983 | 22,056 | 2,610 |
| Dividend Paid | -70,597 | -64,705 | -64,640 | -64,500 | -64,431 |
| Other Financing Activity | -1,518 | -2,379 | -900 | -29,654 | -59 |
| Financing Cash Flow | $-151,132 | $-188,591 | $-279,557 | $932,902 | $-41,880 |
| Exchange Rate Effect | -4,962 | -2,325 | -209 | 10,910 | -10,523 |
| Beginning Cash Position | 227,891 | 227,894 | 253,199 | 207,163 | 273,710 |
| End Cash Position | 209,100 | 227,891 | 227,894 | 253,199 | 207,163 |
| Net Cash Flow | $-13,829 | $2,322 | $-25,096 | $35,126 | $-56,024 |
| Free Cash Flow | |||||
| Operating Cash Flow | 286,283 | 237,436 | 282,565 | 128,636 | 44,662 |
| Capital Expenditure | -40,866 | -38,734 | -31,224 | -31,669 | -32,373 |
| Free Cash Flow | 245,417 | 198,702 | 251,341 | 96,967 | 12,289 |